Journal of Molecular and Cellular Cardiology
Volume 44, Issue 3 , Pages 486-495 , March 2008

Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction

  • Emerson C. Perin

      Affiliations

    • The Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77030, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 713 791 9400; fax: +1 713 795 5651.
    • ,
  • Guilherme V. Silva

      Affiliations

    • The Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77030, USA
    • ,
  • Joao A.R. Assad

      Affiliations

    • The Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77030, USA
    • ,
  • Deborah Vela

      Affiliations

    • The Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77030, USA
    • The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
    • ,
  • L. Maximilian Buja

      Affiliations

    • The Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77030, USA
    • The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
    • ,
  • Andre L.S. Sousa

      Affiliations

    • The Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77030, USA
    • ,
  • Silvio Litovsky

      Affiliations

    • The Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77030, USA
    • ,
  • Jing Lin

      Affiliations

    • The Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77030, USA
    • ,
  • William K. Vaughn

      Affiliations

    • The Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77030, USA
    • ,
  • Stephanie Coulter

      Affiliations

    • The Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77030, USA
    • ,
  • Marlos R. Fernandes

      Affiliations

    • The Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77030, USA
    • The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
    • ,
  • James T. Willerson

      Affiliations

    • The Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77030, USA
    • The University of Texas Health Science Center at Houston, Houston, TX 77030, USA

Received 2 July 2007 ,Revised 30 August 2007 ,Accepted 27 September 2007.

References 

  1. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 2002;106:3009–3017
  2. Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J, et al. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation. 2003;108:2212–2218
  3. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004;94:92–95
  4. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet. 2006;367:113–121
  5. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106:1913–1918
  6. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364:141–148
  7. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210–1221
  8. Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet. 2004;363:783–784
  9. Chazaud B, Hittinger L, Sonnet C, Champagne S, Le Corvoisier P, Benhaiem-Sigaux N, et al. Endoventricular porcine autologous myoblast transplantation can be successfully achieved with minor mechanical cell damage. Cardiovasc Res. 2003;58:444–450
  10. Forrester JS, Price MJ, Makkar RR. Stem cell repair of infarcted myocardium: an overview for clinicians. Circulation. 2003;108:1139–1145
  11. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701–705
  12. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Silva GV, et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation. 2004;110:II213–II218
  13. Kornowski R, Fuchs S. Catheter-based transendocardial gene delivery for therapeutic myocardial angiogenesis. Int J Cardiovasc Intervent. 2000;3:67–70
  14. Perin EC, Silva GV, Sarmento-Leite R. Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation. 2002;106:957–961
  15. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–147
  16. Vale PR, Losordo DW, Milliken CE, Maysky M, Esakof DD, Symes JF, et al. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation. 2000;102:965–974
  17. Kawamoto A, Tkebuchava T, Yamaguchi J, Nishimura H, Yoon YS, Milliken C, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation. 2003;107:461–468
  18. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995;91:1588–1595
  19. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072–1083
  20. Bush LR, Buja LM, Samowitz W, Rude RE, Wathen M, Tilton GD, et al. Recovery of left ventricular segmental function after long-term reperfusion following temporary coronary occlusion in conscious dogs. Comparison of 2- and 4-hour occlusions. Circ Res. 1983;53:248–263
  21. Shake JG, Gruber PJ, Baumgartner WA, Senechal G, Meyers J, Redmond JM, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg. 2002;73:1919–1925[discussion 1926]
  22. Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, Honold J, et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res. 2005;97:1142–1151
  23. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res. 2004;95:9–20
  24. Dai W, Hale SL, Martin BJ, Kuang JQ, Dow JS, Wold LE, et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation. 2005;112:214–223
  25. Müller-Ehmsen J, Krausgrill B, Burst V, Schenk K, Neisen UC, Fries JW, et al. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol. 2006;41:876–884
  26. Hu X, Wang J, Chen J, Luo R, He A, Xie X, et al. Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction. Eur J Cardiothorac Surg. 2007;31:438–443
  27. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A. 2005;102:11474–11479
  28. Hou D, Youssef EA, Brinton TJ, Zhang P, Rogers P, Price ET, et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation. 2005;112:I150–I156
  29. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 2006;27:1114–1122
  30. Agbulut O, Vandervelde S, Al Attar N, Larghero J, Ghostine S, Leobon B, et al. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J Am Coll Cardiol. 2004;44:458–463
  31. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation. 2004;109:1543–1549
  32. Kelly RV, Cohen MG, Runge MS, Stouffer GA. The no-reflow phenomenon in coronary arteries. J Thromb Haemost. 2004;2:1903–1907
  33. Willerson JT, Watson JT, Hutton I, Templeton GH, Fixler DE. Reduced myocardial reflow and increased coronary vascular resistance following prolonged myocardial ischemia in the dog. Circ Res. 1975;36:771–781
  34. Yoon YS, Park JS, Tkebuchava T, Luedeman C, Losordo DW. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation. 2004;109:3154–3157

PII: S0022-2828(07)01241-2

doi: 10.1016/j.yjmcc.2007.09.012

Journal of Molecular and Cellular Cardiology
Volume 44, Issue 3 , Pages 486-495 , March 2008

Article Tools

* Image Usage & Resolution